ALMSTEAD, NEIL G.,HWANG, PETER SEONGWOO,MOON, YOUNG-CHOON
申请号：
PL12185448
公开号：
PL2559689T3
申请日:
2007.09.24
申请国别(地区):
PL
年份:
2018
代理人:
摘要：
The present invention relates to preparation processes for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay.
